Pembrolizumab-Induced Triple M Syndrome in a Patient with Stage III Melanoma: A Case Report
Santiago Imhoff, MD, Kemar Barrett, MD, Maxwel Janosky, MD, Natasha Rastogi, MD
PDF
JPG
|
Research Day